- 全部删除
您的购物车当前为空
GRKs-IN-1 has remarkable potency against and selectivity for G protein-coupled receptor kinase 2 GRK2 (IC50: 130 nM) and GRK5 (IC50: 7.1 μM).

GRKs-IN-1 has remarkable potency against and selectivity for G protein-coupled receptor kinase 2 GRK2 (IC50: 130 nM) and GRK5 (IC50: 7.1 μM).
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 18,300 | 3-6月 | |
| 50 mg | ¥ 24,300 | 3-6月 | |
| 100 mg | ¥ 31,500 | 3-6月 |
CCG258208 相关产品
| 产品描述 | GRKs-IN-1 has remarkable potency against and selectivity for G protein-coupled receptor kinase 2 GRK2 (IC50: 130 nM) and GRK5 (IC50: 7.1 μM). |
| 靶点活性 | GRK5:7.1 μM, GRK2:30 nM |
| 体外活性 | GRKs-IN-1 (Compound 14as) is a derivative 14as of paroxetine, shows a 100-fold improvement in cardiomyocyte contractility assays over paroxetine. |
| 别名 | GRK2-IN-1 |
| 分子量 | 452.48 |
| 分子式 | C24H25FN4O4 |
| CAS No. | 2055990-90-2 |
| 密度 | 1.314 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容